Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HLA Antigens”

157 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 157 results

Testing effectiveness (Phase 2)Study completedNCT01386619
What this trial is testing

NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic Syndromes+3 more
University Hospital, Basel, Switzerland 15
Not applicableUnknownNCT03815864
What this trial is testing

Antibodies and Liver Retransplantation

Who this might be right for
Liver Transplant FailureAntibody-mediated Rejection
London Health Sciences Centre 200
Testing effectiveness (Phase 2)Study completedNCT00681330
What this trial is testing

Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Tokyo University 14
Testing effectiveness (Phase 2)Ended earlyNCT00683085
What this trial is testing

Human Leukocyte Antigen-A*02:01-restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreas Neoplasms
Tokyo University 2
Testing effectiveness (Phase 2)Study completedNCT00681421
What this trial is testing

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Tokyo University 14
Testing effectiveness (Phase 2)Ended earlyNCT05100316
What this trial is testing

Screening Protocol for Preliminary Eligibility Determination for Adoptive Cell Therapy Trials

Who this might be right for
Neoplasms
GlaxoSmithKline 16
Early research (Phase 1)Study completedNCT00586690
What this trial is testing

Safety Trial of NK DLI From 6/6 HLA Matched Family Member Following Nonmyeloablative ASCT

Who this might be right for
Lymphoma
David Rizzieri, MD 47
Early research (Phase 1)WithdrawnNCT05037669
What this trial is testing

Programmed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor (PACE CART19) in Patients With Relapsed Or Refractory CD19+ Leukemia and Lymphoma

Who this might be right for
Acute Lymphoblastic LeukemiaChronic Lymphocytic LeukemiaNon Hodgkin Lymphoma
University of Pennsylvania
Early research (Phase 1)Study completedNCT02289196
What this trial is testing

Safety Study of Vx006 Vaccine in Solid Tumor Patients

Who this might be right for
Solid Tumor
Vaxon Biotech 23
Not applicableLooking for participantsNCT07134491
What this trial is testing

Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity

Who this might be right for
Antibody Mediated Rejection After Kidney Transplantation
Assistance Publique - Hôpitaux de Paris 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT05092347
What this trial is testing

Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)

Who this might be right for
Chronic Kidney Disease (CKD)
Regeneron Pharmaceuticals 43
Not applicableLooking for participantsNCT05124288
What this trial is testing

Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for the Generation of Guidelines and Personalized Therapeutic Pathways

Who this might be right for
Acute Myeloid Leukemia, in Relapse
Ciceri Fabio 500
Very early researchStudy completedNCT00874861
What this trial is testing

HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas

Who this might be right for
AstrocytomaOligoastrocytomaOligodendroglioma
Ian F. Pollack, M.D. 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05234190
What this trial is testing

Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients

Who this might be right for
Rejection; Transplant, LiverLiver FailureLiver Diseases
Quell Therapeutics Limited 33
Not applicableUnknownNCT01626105
What this trial is testing

Personalized Prediction of Tolerance and Immunogenicity in Hemophilia

Who this might be right for
Hemophilia A
Victor J Marder, M.D. 55
Not applicableStudy completedNCT03438058
What this trial is testing

Complement-activating Anti-human Leucocyte Antigen Donor Specific Antibodies in Solid Organ Transplantation

Who this might be right for
Organ Transplant Recipients
Paris Translational Research Center for Organ Transplantation 7,547
Testing effectiveness (Phase 2)Study completedNCT01105273
What this trial is testing

Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic Anemia

Who this might be right for
Aplastic Anemia
Asan Medical Center 12
Early research (Phase 1)Looking for participantsNCT03943238
What this trial is testing

TLI, TBI, ATG & Hematopoietic Stem Cell Transplantation and Recipient T Regs Therapy in Living Donor Kidney Transplantation

Who this might be right for
Living Donor Kidney Transplantation
Stanford University 22
Not applicableUnknownNCT03861962
What this trial is testing

Re-evaluation of Donor-specific Anti-HLA Alloantibodies Immunoassay After Organ Transplantation, From Antigen Level to Epitope Level

Who this might be right for
Organ Transplantation
Assistance Publique - Hôpitaux de Paris 20,000
Testing effectiveness (Phase 2)Study completedNCT00005804
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Fred Hutchinson Cancer Center
Next Page